Back to All Ideas
Stock Analysis·1:29 PM ET · May 28, 2026·3 min read

Truist Raises NVDA Price Target to $307, Maintains Buy Rating

NASDAQ:NVDA

Alpha Stocks Insight Staff

Independent stock news and analysis covering NASDAQ and NYSE markets.

Share
NASDAQ:NVDA article header

Truist lifted its NVIDIA price target to $307 from $287 after a strong quarter — here's what the analyst move means for NVDA investors.

Truist raised its price target on NVIDIA Corporation (NASDAQ: NVDA) to $307 from $287 on May 21, while maintaining a Buy rating on the stock. The revision follows NVIDIA's most recently reported quarter and signals continued conviction among Wall Street analysts in the chipmaker's growth trajectory. NVDA last traded at $212.60 on Wednesday, May 27, down $2.26 on the session.

What Changed: Truist's Updated Call

  • Truist increased its price target on NVDA to $307, up from a prior target of $287.
  • The Buy rating was maintained, reflecting no change in the firm's overall directional view.
  • The target revision was reported by TheFly on May 21, 2026.
  • At the current trading price of $212.60, the new $307 target implies meaningful upside from present levels.

Why It Matters

Analyst price target revisions following a quarterly report are a direct signal of how institutional research desks are adjusting their valuation models after digesting new financial disclosures. Truist's decision to lift its target — rather than simply reaffirm the prior figure — suggests the firm found sufficient evidence in NVIDIA's most recent results to justify a higher ceiling on the stock's fair value.

For a company of NVIDIA's scale, incremental upward revisions from major banks carry weight because they can influence the price expectations of institutional portfolio managers. A $20 target increase on a stock with a market capitalization of $5.15 trillion represents a recalibration that goes beyond routine maintenance of a rating.

Wall Street View

The broader analyst community remains firmly constructive on NVIDIA. As of the most recent consensus snapshot dated May 1, 2026, 24 analysts rated the stock Strong Buy, 42 rated it Buy, 4 rated it Hold, and just 1 rated it Sell, with no Strong Sell recommendations on record — an unusually lopsided distribution in favor of bulls. That consensus was unchanged from the prior period dated April 1, 2026, suggesting Truist's target raise reflects individual model updates rather than a sector-wide sentiment shift. The forward price-to-earnings ratio of 16.8x (TTM — may not reflect latest quarter) indicates the market is pricing in continued growth, a view Truist's revised target appears to endorse.

Investor Takeaway

Truist's upward price target revision to $307 adds to an already heavily bullish analyst backdrop for NVIDIA, where Buy-or-better ratings account for the overwhelming majority of active coverage. Investors tracking institutional sentiment will note that the revision came directly on the heels of NVIDIA's most recent quarterly disclosure, lending it fundamental grounding rather than purely technical motivation. With 66 analysts holding Buy or Strong Buy ratings and only one dissenting Sell, the Wall Street consensus leaves little ambiguity about where professional opinion currently sits on NVDA.

NVDANVIDIAanalyst ratingprice target

Found this useful? Share it:

Share

Related Articles

Important Legal Disclaimer

This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.

Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.

Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.